U.S. Gastroenterology Ambulatory Surgery Center Market (By Ownership: Hospital-affiliated, Freestanding, Corporation-owned) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

The U.S. gastroenterology ambulatory surgery center market is expected to surpass around USD 12.96 billion by 2030, poised to grow at a CAGR of 6.05% from 2022 to 2030.

The growth can be attributed to cost-efficiency, improved patient outcomes, and patient convenience provided by the ambulatory surgery centers. In addition, factors such as rising prevalence of digestive diseases and growing geriatric population are expected to fuel the growth.

Establishment and maintenance of hospitals and other healthcare settings are capital-intensive. In addition, high cost of hospitalization associated with inpatient admission has led to increased patient preference for outpatient facilities over hospital visits. The number of ambulatory surgery centers (ASCs) in U.S. has witnessed a surge in the last few years in order to fulfill the growing demand for alternate surgical facilities. Currently, there are more than 9,280 ASCs in U.S. with highest concentration in California, Florida, and Texas.

The other segment includes ASCs owned by various joint ventures such as physician-hospital, physician-hospital-corporate, and physician-corporate gastroenterology. The physician-hospital joint-venture ASCs are gaining traction due to better patient outcomes, enhanced productivity, and ownership interest.

The rising number of partnerships and acquisitions is a key factor expected to drive the growth of the market. In February 2019, SurgCenter Development entered into an agreement with Surgery Partners to develop new ambulatory surgery centers.

Key industry participants among the service provider include Envision Healthcare Corporation; Tenet Healthcare Corporation; Surgery Partners; Community Health Systems, Inc. (CHS); Universal Health Service (UHS); Hospital Corporation of America (HCA); Surgery Care Affiliates (SCA); SurgCenter Development; Covenant Surgical Partners; and Regent Surgical Health.

Ownership Insights

On the basis of ownership, the U.S. gastroenterology ambulatory surgery center market has been segmented into hospital-affiliated, freestanding/physician-owned, corporation-owned, and others. The other segment includes ventures between physician-hospital, physician-corporation, and physician-corporation-hospital. The freestanding segment (mainly comprising physician-owned ambulatory surgery centers) accounted for the highest market share in 2018, owing to maximum professional control over the clinical environment and quality of care delivered to patients. It allows physicians to focus on a small number of procedures in a single setting. With hands-on control, physicians maintain quality control processes in ASCs within a smaller space and fewer operating rooms as compared to hospitals.

The rising burden of surgical procedures in the hospital increases the demand for ASC to perform various procedures such as urology, gastrointestinal, and ophthalmic surgery. Endoscopic Ambulatory Surgery Centers (EASC) are the freestanding facilities designated to carry out gastrointestinal procedures at a low cost. These facilities are more competent than the hospital and offer an added source of revenue to the healthcare providers. According to Becker’s review of GI and Endoscopy in ASCs, in the U.S., around 25% of all cases in ASCs involve GI/endoscopic procedures. Also, more than 27% of all the single-specialty surgery centers are driven due to gastroenterology procedure

Regional Insights

The high adoption rate of advanced surgical procedures such as minimally invasive surgeries and new endoscopy technologies are the key factors driving the ambulatory surgery centers market in U.S. In addition, the high cost of medical services offered by physicians in the country and unnecessary hospitalization, create the need for cost-effective and efficient treatment options for patients seeking treatment. According to the data published by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 60 to 70 million people suffer from gastrointestinal diseases each year in U.S. The most common diseases include Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), indigestion, constipation, diarrhea, and abdominal pain.

Key Players

• Cardinal Health
• Medtronic PLC
• Ethicon (Johnson & Johnson)
• Boston Scientific, Olympus
• Becton Dickinson (BD)
• Hill-Rom Holdings
• GE Healthcare
• Koninklijke Philips N.V.
• Cook Medical

Market Segmentation

• By Ownership Outlook

• Hospital-Affiliated
• Freestanding
• Corporation-Owned
• Others
• By Regional Outlook
• U.S.